Previous close | 3.9100 |
Open | 3.9100 |
Bid | 3.3000 |
Ask | 4.9000 |
Strike | 12.50 |
Expiry date | 2024-05-17 |
Day's range | 3.9100 - 3.9100 |
Contract range | N/A |
Volume | |
Open interest | 18 |
Strong Performance with Significant Growth in Net Product Revenue
Innoviva ( NASDAQ:INVA ) First Quarter 2024 Results Key Financial Results Revenue: US$77.5m (up 1.5% from 1Q 2023). Net...
BURLINGAME, Calif., May 08, 2024--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today reported financial results for the first quarter ended March 31, 2024, and highlighted select corporate achievements.